A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis
Brandon Kirsch, Janet DuBois, Deepak Chadha
Abstract not available.
hyperhidrosis; axillary; sofpironium bromide; children; adolescents; pharmokinetics
Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis; an update on prevalence and severity in the United States. Arch Dermatol Res. 2016; 308:743-749.
Abstract - 103 Poster PDF - 26
- There are currently no refbacks.